Justin Bowers
Stock Analyst at Deutsche Bank
(1.77)
# 3,311
Out of 4,981 analysts
40
Total ratings
33.33%
Success rate
3.82%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $295.39 | +6.64% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $490.64 | -12.36% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $187.22 | +41.54% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $10.10 | +127.72% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.15 | +30.93% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $12.64 | +97.78% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $113.54 | +36.52% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $479.46 | +27.23% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $51.26 | +59.97% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $12.31 | +103.09% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.65 | +541.51% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $175.01 | +71.42% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $190.05 | +44.70% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $253.50 | -1.38% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $152.89 | +89.68% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $12.51 | +267.71% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $295.39
Upside: +6.64%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $490.64
Upside: -12.36%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $187.22
Upside: +41.54%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $10.10
Upside: +127.72%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.15
Upside: +30.93%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $12.64
Upside: +97.78%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $113.54
Upside: +36.52%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $479.46
Upside: +27.23%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $51.26
Upside: +59.97%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $12.31
Upside: +103.09%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.65
Upside: +541.51%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $175.01
Upside: +71.42%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $190.05
Upside: +44.70%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $253.50
Upside: -1.38%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $152.89
Upside: +89.68%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $12.51
Upside: +267.71%